BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.71B |
| 2 |
Alibaba
BABA
|
+$2.19B |
| 3 |
Truist Financial
TFC
|
+$2.16B |
| 4 |
iShares MBS ETF
MBB
|
+$841M |
| 5 |
ServiceNow
NOW
|
+$829M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$5.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$2.34B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$983M |
| 4 |
VIAB
Viacom Inc. Class B
VIAB
|
+$684M |
| 5 |
Apple
AAPL
|
+$623M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Financials | 14.42% |
| 3 | Healthcare | 13.59% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
iShares Ultra Short Duration Bond Active ETF
ICSH
$8.4B
| $16M | ﹤0.01% |
318,529
-243,669
| -43% | -$12.3M |
|
|
HALL
3002
DELISTED
Hallmark Financial Services, Inc.
HALL
| $16M | ﹤0.01% |
91,237
-16,028
| -15% | -$2.93M |
|
|
CHNGU
3003
DELISTED
Change Healthcare Inc. Tangible Equity Units
CHNGU
| $16M | ﹤0.01% |
266,957
+30,606
| +13% | +$1.57M |
|
|
ACOR
3004
DELISTED
Acorda Therapeutics
ACOR
| $16M | ﹤0.01% |
65,326
+37
| +0.1% | +$9.34K |
|
3005
Harmony Gold Mining
HMY
$12.3B
| $16M | ﹤0.01% |
4,403,555
-347,215
| -7% | -$1.11M |
|
|
UBX
3006
DELISTED
Unity Biotechnology
UBX
| $15.9M | ﹤0.01% |
220,933
+14,661
| +7% | +$1.03M |
|
3007
Rocky Brands
RCKY
$368M
| $15.9M | ﹤0.01% |
541,183
-92,831
| -15% | -$2.74M |
|
3008
ADMA Biologics
ADMA
$2.23B
| $15.9M | ﹤0.01% |
3,971,107
+826,035
| +26% | +$3.6M |
|
|
MOR
3009
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $15.9M | ﹤0.01% |
445,211
-63,228
| -12% | -$1.89M |
|
3010
Mitek Systems
MITK
$822M
| $15.8M | ﹤0.01% |
2,070,516
-11,698
| -0.6% | -$98.7K |
|
3011
Aprea Therapeutics
APRE
$8.4M
| $15.8M | ﹤0.01% |
+17,198
| New | +$9.47M |
|
|
PTVCB
3012
DELISTED
Protective Insurance Corporation Class B Common Stock
PTVCB
| $15.7M | ﹤0.01% |
977,937
-23,895
| -2% | -$389K |
|
3013
VanEck Gold Miners ETF
GDX
$27.3B
| $15.7M | ﹤0.01% |
536,022
-368,978
| -41% | -$10.1M |
|
3014
Banco Bilbao Vizcaya Argentaria
BBVA
$157B
| $15.7M | ﹤0.01% |
2,810,795
-1,327,249
| -32% | -$7.07M |
|
3015
TC Energy
TRP
$65.4B
| $15.6M | ﹤0.01% |
292,127
-168,037
| -37% | -$8.62M |
|
|
IOTS
3016
DELISTED
Adesto Technologies Corp
IOTS
| $15.5M | ﹤0.01% |
1,826,423
+3,610
| +0.2% | +$28.4K |
|
|
HABT
3017
DELISTED
The Habit Restaurants, Inc. - Class A
HABT
| $15.5M | ﹤0.01% |
1,485,031
-7,063
| -0.5% | -$70.3K |
|
3018
Xeris Biopharma Holdings
XERS
$1.45B
| $15.5M | ﹤0.01% |
2,196,747
+65,498
| +3% | +$541K |
|
3019
Boston Omaha
BOC
$433M
| $15.4M | ﹤0.01% |
733,032
+73,342
| +11% | +$1.54M |
|
3020
Cloudflare
NET
$109B
| $15.4M | ﹤0.01% |
899,999
+19,903
| +2% | +$339K |
|
|
KALV
3021
DELISTED
KalVista Pharmaceuticals
KALV
| $15.3M | ﹤0.01% |
860,633
+94,121
| +12% | +$1.23M |
|
3022
Lands' End
LE
$404M
| $15.3M | ﹤0.01% |
911,565
+19,099
| +2% | +$250K |
|
|
DLA
3023
DELISTED
Delta Apparel Inc.
DLA
| $15.3M | ﹤0.01% |
492,393
+15,212
| +3% | +$407K |
|
|
HMTV
3024
DELISTED
Hemisphere Media Group, Inc.
HMTV
| $15.3M | ﹤0.01% |
1,028,139
+5,571
| +0.5% | +$72.6K |
|
3025
PUT
VanEck Semiconductor ETF
SMH
$70.9B
| $15.2M | ﹤0.01% |
215,000
+12,000
| +6% | +$786K |
|
Similar funds
BlackRock's Q4 2019 Portfolio in Review
As of Q4 2019, BlackRock held 5,193 positions worth $2.61T, up 9.5% from $2.38T the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock's Q4 2019 filing shows 167 new, 2,887 increased, 1,450 reduced and 161 closed positions. Its largest new stake was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M. The largest sale was Celgene Corp, an estimated $5.15B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- BlackRock's largest Q4 2019 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M.
- BlackRock added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.71B increase.
- BlackRock's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $983M.
- BlackRock fully exited Celgene Corp in Q4 2019, selling an estimated $5.15B.
- BlackRock's ten largest holdings make up 15% of its $2.61T portfolio in Q4 2019.
- BlackRock opened 167 new positions and closed 161 in Q4 2019.
- BlackRock's portfolio value rose 9.5% quarter-over-quarter to $2.61T.
Based on BlackRock's 13F filing for Q4 2019, filed 13 Feb 2020.